Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study
曲妥珠单抗、帕妥珠单抗和吡咯替尼三联HER2阻断疗法与HER2双联阻断疗法在HER2阳性乳腺癌新辅助治疗中的比较:一项随机II期研究
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70611
Huang, Jiahui; Wang, Haoyu; Tong, Yiwei; Hong, Jin; Zhu, Yifei; Ren, Weili; Yu, Jing; Shi, Haoting; Gao, Weiqi; Zhu, Siji; Wu, Jiayi; Huang, Ou; Li, Jing; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Chen, Xiaosong